The Microcirculation as a Foundation of Cardiovascular Disease
Microvascular Involvement in Cardiac Pathology

https://doi.org/10.1006/jmcc.1998.0824Get rights and content

Abstract

Abnormalities of the microvasculature are centrally involved in the pathogenesis of some forms of heart disease, but in others are consequences of it. Microvascular abnormalities may contribute to the progression of viral myocarditis and Chagas' disease. Focal abnormalities may occur early in some cardiomyopathies and do occur later in most types of myocarditis. The thickening of arteriolar walls in chronic hypertension is likely to contribute significantly to the impairment of coronary haemodynamics associated with adaptive ventricular hypertrophy and the consequent diminution of coronary reserve, increasing diffusion distances and failure of angiogenesis to compensate. However, the resulting myocyte necrosis stimulates inflammatory angiogenesis. When ischemic myocyte injury becomes irreversible there is a concomitant loss of capacity for reperfusion, the no-reflow phenomenon. Less severe temporary ischemia reduces the proportion of functional capillaries. Multiple mechanisms are involved in this microvascular stunning, including: reperfusion injury; leukocyte activation, adhesion and accumulation; and impaired endothelium-dependent vasodilation. Many of the microvascular changes are those of the inflammatory response to cell death and form part of a final common pathway in myocarditis, cardiomyopathy, cardiac hypertrophy and failure, and ischemic heart disease. Stimulation of angiogenesis prior to myocyte necrosis in hypertrophy and control of leukocyte activity in ischemic heart disease could minimize myocyte loss.

References (0)

Cited by (76)

  • IL-1β reduces cardiac lymphatic muscle contraction via COX-2 and PGE<inf>2</inf> induction: Potential role in myocarditis

    2018, Biomedicine and Pharmacotherapy
    Citation Excerpt :

    Myocarditis has been closely implicated with the pathogenesis of sudden death, dilated cardiomyopathy (DCM) and heart failure (HF) [3,4]. Despite many investigations revealing microvascular changes in myocarditis and DCM, research into the roles played by the lymphatic vasculature in such cardiopathies has been comparatively neglected [5]. The main function of the cardiac lymphatic system is to regulate interstitial fluid pressure, thus maintaining tissue homeostasis and preventing myocardial edema [6].

View all citing articles on Scopus

Please address all correspondence to: Professor J. B. Gavin, Department of Pathology, University of Auckland School of Medicine, Private Bag 92019, Auckland, New Zealand.

View full text